Now that the US Army has extracted itself from Iraq, its medical authorities have begun the task of tackling a significant long-term consequence of such overseas intervention. Physicians in the employ of the armed forces have announced they will embark on widespread clinical trials to assess the efficacy of treatments that are being widely prescribed for post-traumatic stress disorder (PTSD).
French premier Francois Hollande may be all for change in terms of his country’s economic strategy and renegotiating the close Franco-German relationship forged by his predecessor. But, when it comes to healthcare, the new left-wing election victor appears determined to stick to the taxpharma agenda laid down by Nicolas Sarkozy. And that’s not good news for industry in a country where its reputation has already been substantially tarnished by a medicines safety scandal.